Want to see TSE:CHGX full AI Analyst Report?
ChitogenX (CHGX) Ratios
ChitogenX Ratios
TSE:CHGX's free cash flow for Q3 2025 was $36.00K. For the 2025 fiscal year, TSE:CHGX's free cash flow was increased by $0.00 and operating cash flow was $36.00K. See a summary of the company’s cash flow.
| Ratios | Apr 24 | Apr 23 | Apr 22 | Apr 21 | Apr 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.07 | 0.05 | 0.39 | 1.23 | 0.44 |
| Quick Ratio | 0.07 | 0.05 | 0.39 | 1.23 | 0.44 |
| Cash Ratio | 0.01 | 0.01 | 0.17 | 1.03 | 0.18 |
| Solvency Ratio | -0.23 | -0.58 | -0.59 | -0.73 | -0.64 |
| Operating Cash Flow Ratio | -0.31 | -0.44 | -1.72 | -1.29 | -0.94 |
| Short-Term Operating Cash Flow Coverage | -1.69 | -1.00 | -3.45 | -1.61 | -2.67 |
| Net Current Asset Value | $ -6.48M | $ -10.19M | $ -7.50M | $ -2.24M | $ -2.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 7.26 | 7.54 | 5.08 | 1.41 | 2.03 |
| Debt-to-Equity Ratio | -0.63 | -0.57 | -0.80 | -2.56 | -1.09 |
| Debt-to-Capital Ratio | -1.68 | -1.30 | -4.10 | 1.64 | 12.42 |
| Long-Term Debt-to-Capital Ratio | -1.13 | -0.32 | -2.05 | 2.86 | -4.62 |
| Financial Leverage Ratio | -0.09 | -0.07 | -0.16 | -1.82 | -0.54 |
| Debt Service Coverage Ratio | -0.47 | -0.99 | -1.53 | -0.90 | -1.97 |
| Interest Coverage Ratio | -3.25 | -3.48 | -2.95 | -3.66 | -6.77 |
| Debt to Market Cap | 0.62 | 0.44 | 0.47 | 0.23 | 0.41 |
| Interest Debt Per Share | 0.06 | 0.14 | 0.20 | 0.19 | 0.12 |
| Net Debt to EBITDA | -5.73 | -1.15 | -1.57 | -0.88 | -1.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 97.33% | 96.26% | 96.67% | 92.56% |
| EBT Per EBIT | 56.80% | 130.85% | 145.60% | 127.52% | 112.80% |
| Return on Assets (ROA) | -291.01% | -844.17% | -438.20% | -115.11% | -193.32% |
| Return on Equity (ROE) | 25.15% | 63.29% | 69.27% | 209.44% | 103.71% |
| Return on Capital Employed (ROCE) | 100.04% | 75.45% | 470.64% | -316.77% | 586.95% |
| Return on Invested Capital (ROIC) | 127.91% | 145.03% | -1797.78% | -105.12% | -1050.33% |
| Return on Tangible Assets | -582.02% | -1419.13% | -622.12% | -129.49% | -279.24% |
| Earnings Yield | -25.04% | -49.65% | -40.87% | -18.74% | -39.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.02 | 0.04 | 0.15 | 0.37 | 0.12 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -19040.83 | -9180.68 | -2465.07 | -988.37 | -3061.09 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 19040.83 | 9180.68 | 2465.07 | 988.37 | 3061.09 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.07 | -0.09 | -0.10 | -0.06 |
| Free Cash Flow Per Share | -0.01 | -0.07 | -0.09 | -0.10 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -97.58 | -993.67 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -97.58 | -993.67 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.26 | -0.57 | -0.56 | -0.65 | -0.61 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -16.26% | -25.48% | -27.02% | -14.83% | -25.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.99 | -2.01 | -2.45 | -5.34 | -2.54 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -1.00 | -1.27 | -1.69 | -11.17 | -2.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.15 | -3.92 | -3.70 | -6.74 | -3.97 |
| Price-to-Operating Cash Flow Ratio | -6.15 | -3.92 | -3.74 | -6.75 | -3.97 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | 0.28 | -0.32 | -0.18 | -0.79 |
| Enterprise Value Multiple | -14.99 | -3.79 | -5.07 | -8.80 | -4.17 |
| Enterprise Value | 10.05M | 18.00M | 17.44M | 22.36M | 8.62M |
| EV to EBITDA | -14.99 | -3.79 | -5.07 | -8.80 | -4.17 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -9.96 | -5.63 | -5.36 | -7.49 | -5.42 |
| EV to Operating Cash Flow | -9.96 | -5.63 | -5.42 | -7.50 | -5.42 |
| Tangible Book Value Per Share | -0.09 | -0.21 | -0.21 | -0.08 | -0.11 |
| Shareholders’ Equity Per Share | -0.08 | -0.20 | -0.20 | -0.06 | -0.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.03 | 0.04 | 0.03 | 0.07 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.13 | -0.14 | -0.13 | -0.10 |
| Tax Burden | 1.00 | 0.97 | 0.96 | 0.97 | 0.93 |
| Interest Burden | 2.18 | 1.33 | 1.39 | 1.48 | 1.33 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.65 | 0.51 | 0.65 | 0.79 | 0.64 |
Currency in CAD
